StocksFundsScreenerSectorsWatchlists
UG

UG - United-Guardian Inc Stock Price, Fair Value and News

8.42USD+0.28 (+3.44%)Market Closed

Market Summary

UG
USD8.42+0.28
Market Closed
3.44%

UG Stock Price

View Fullscreen

UG RSI Chart

UG Valuation

Market Cap

38.1M

Price/Earnings (Trailing)

14.75

Price/Sales (Trailing)

3.5

EV/EBITDA

8.89

Price/Free Cashflow

12.79

UG Price/Sales (Trailing)

UG Profitability

Operating Margin

51.30%

EBT Margin

29.86%

Return on Equity

22.67%

Return on Assets

19.98%

Free Cashflow Yield

7.82%

UG Fundamentals

UG Revenue

Revenue (TTM)

10.9M

Rev. Growth (Yr)

-5.64%

Rev. Growth (Qtr)

-14.73%

UG Earnings

Earnings (TTM)

2.6M

Earnings Growth (Yr)

8.57%

Earnings Growth (Qtr)

17.66%

Breaking Down UG Revenue

Last 7 days

5.5%

Last 30 days

8.6%

Last 90 days

10.5%

Trailing 12 Months

-17.3%

How does UG drawdown profile look like?

UG Financial Health

Current Ratio

7.99

UG Investor Care

Dividend Yield

13.68%

Dividend/Share (TTM)

1.1

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202311.4M10.4M11.0M10.9M
202214.4M14.4M13.6M12.7M
202111.1M11.8M12.6M13.9M
202013.1M12.9M11.9M11.0M
201913.1M12.5M12.4M0
201814.2M14.2M14.3M13.6M
201711.7M13.4M13.1M13.4M
201612.0M10.1M10.0M11.1M
201513.9M15.0M16.1M14.0M
201415.4M14.8M13.9M13.4M
201313.9M13.8M13.7M15.4M
201214.6M14.3M14.4M13.8M
201113.9M14.0M14.2M14.3M
201000013.7M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of United-Guardian Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 19, 2021
globus kenneth h
gifted
-
-
-8,400
president
Mar 05, 2020
globus kenneth h
gifted
-
-
-8,000
president
May 20, 2019
globus kenneth h
gifted
-
-
-5,600
president

1–3 of 3

Which funds bought or sold UG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
Northstar Group, Inc.
reduced
-23.17
-17,966
80,480
0.02%
Mar 11, 2024
VANGUARD GROUP INC
added
1.48
-29,295
959,364
-%
Mar 08, 2024
ICA Group Wealth Management, LLC
new
-
2,592
2,592
-%
Feb 14, 2024
GAMCO INVESTORS, INC. ET AL
added
0.97
-40,185
1,123,200
0.01%
Feb 14, 2024
BANK OF AMERICA CORP /DE/
unchanged
-
-1.00
7.00
-%
Feb 14, 2024
Ameritas Advisory Services, LLC
reduced
-31.54
-134,450
254,823
0.01%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
76,385
76,385
-%
Feb 14, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
unchanged
-
-4,444
96,955
-%
Feb 14, 2024
Royal Bank of Canada
reduced
-24.07
-
1,000
-%

1–10 of 33

Are Funds Buying or Selling UG?

Are funds buying UG calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own UG
No. of Funds

Unveiling United-Guardian Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
renaissance technologies llc
4.13%
189,663
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.01%
230,263
SC 13G/A
Feb 11, 2021
renaissance technologies llc
5.84%
268,123
SC 13G/A
Feb 13, 2020
renaissance technologies llc
5.94%
272,800
SC 13G/A

Recent SEC filings of United-Guardian Inc

View All Filings
Date Filed Form Type Document
Apr 15, 2024
ARS
ARS
Apr 09, 2024
DEF 14A
DEF 14A
Mar 22, 2024
8-K
Current Report
Mar 22, 2024
10-K
Annual Report
Mar 01, 2024
8-K
Current Report
Feb 02, 2024
8-K
Current Report

Peers (Alternatives to United-Guardian Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
383.7B
84.1B
1.49% 3.96%
25.37
4.56
3.82% 5.63%
73.2B
19.5B
0.26% 14.38%
31.81
3.76
8.29% 28.85%
52.8B
15.2B
5.87% -40.36%
109.39
3.49
-7.33% -68.01%
26.2B
5.9B
4.24% 16.09%
34.64
4.46
9.16% 82.56%
18.3B
7.3B
-1.83% -10.39%
229.24
2.51
3.47% -81.61%
10.5B
6.0B
1.04% -1.68%
32.35
1.74
14.07% 132.95%
9.8B
890.1M
-11.67% 91.24%
75.8
11.02
79.24% 176.22%
MID-CAP
4.2B
1.3B
-3.66% -15.21%
27.38
3.17
21.26% 26.23%
2.9B
8.1B
-8.45% -39.96%
-7.52
0.36
-14.02% -296.95%
2.6B
872.0M
-24.40% 10.19%
-109.62
2.96
65.49% 64.15%
2.4B
2.0B
-20.46% 9.32%
14.09
1.18
-3.26% 17.67%
SMALL-CAP
1.9B
2.3B
1.89% -12.32%
17.82
0.84
4.31% 6.67%
149.0M
191.5M
-5.89% 56.57%
8.38
0.78
-1.27% 486.29%
52.9M
259.3M
-11.11% 216.67%
-1.22
0.2
-19.36% 50.71%
38.1M
10.9M
8.65% -17.27%
14.75
3.5
-14.28% 0.46%

United-Guardian Inc News

Latest updates
GuruFocus.com37 hours ago
Defense World15 Apr 202406:51 am
InvestorPlace25 Mar 202407:00 am
InvestorPlace25 Mar 202407:00 am
InvestorPlace22 Mar 202407:00 am

United-Guardian Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q32019Q22019Q12018Q42018Q3
Revenue-14.7%2,6073,0582,6502,5702,7632,4173,6263,8923,6613,1803,6583,4312,3722,3362,9553,3233,3173,2793,1802,6643,344
Costs and Expenses-22.3%1,8162,3362,1321,7392,1171,7292,4262,3892,3041,9102,1421,9061,8641,5831,8912,0122,0362,0631,9341,8531,815
Operating Expenses2.0%498488574518475532620547607459513457506493512515544502547545519
  R&D Expenses12.2%11098.0012912712612111213213013113088.0012011510910810594.0099.0010898.00
EBITDA Margin4.1%0.31*0.30*0.28*0.28*0.26*0.29*0.33*0.39*0.43*0.43*0.42*----------
Income Taxes20.6%19316011919616589.00165239287267354311147188313208284274325112350
Earnings Before Taxes18.3%9317875809528444347991,1511,4031,2841,6991,4927589061,5009981,3541,3531,5486951,666
EBT Margin4.2%0.30*0.29*0.27*0.27*0.25*0.28*0.32*0.38*0.42*0.41*0.41*----------
Net Income17.7%7376274617566793466339111,1161,0171,3451,1816117181,1877901,0701,0791,2235831,317
Net Income Margin3.8%0.24*0.23*0.22*0.21*0.20*0.22*0.26*0.30*0.33*0.33*0.33*----------
Free Cashflow-5.7%1,0341,0964334156106881,13023.001,6309881,617----------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets6.2%12,92312,17311,87711,94010,64011,67611,68112,94112,24213,62612,42613,32011,92012,84712,83013,29812,36313,53412,50313,97012,545
  Current Assets5.5%12,25311,61611,36311,2429,97110,87511,07912,31211,58312,96211,78412,65311,24712,14812,11312,54211,56712,70111,69813,14211,687
    Cash Equivalents15.8%8,2437,1166,4831,2028304973565125316927448625918852,2077901,0481,795911499550
  Inventory-0.4%1,2241,2281,7792,4701,6722,2951,7281,4981,4111,2879181,3331,4161,5451,5231,3631,2171,2741,3011,3251,482
  Net PPE11.1%619557514537559616603629659664642667674696710745781814783803828
  Current Liabilities4.1%1,5341,4741,3541,9181,3741,6641,9832,0102,3381,7071,4501,5711,4141,2182,0251,5721,3431,5291,5951,5581,366
Shareholder's Equity6.9%11,38910,65110,48410,0239,26710,0129,66610,7339,82111,69110,67511,53610,35411,39810,68011,42410,63311,76910,70012,14810,925
  Retained Earnings7.2%10,92910,19210,0249,5638,8079,5529,20710,2739,36211,23210,21511,0769,89510,93810,22110,96410,17311,31010,24011,68810,466
Accumulated Depreciation0.4%7,0967,0657,0407,0156,9916,9726,9386,9046,8706,8316,8306,7956,7606,7206,6846,6476,6106,5676,5266,4876,449
Shares Outstanding0%4,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,594---------
Float---37,949---68,869---68,961---48,900---49,131--
Cashflow (Last 12 Months)
(In )
Cashflow (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-3.2%1,127,5701,164,663434,658417,589624,713735,8551,137,18627,4151,664,5331,031,4361,627,102990,206672,536-261,7751,896,1841,287,295849,098984,2011,111,1581,531,6541,041,942
Cashflow From Investing99.2%-579-72,0524,846,296-46,0881,133,313-594,901406,278-47,1281,160,176-1,083,976459,926-719,601687,310-1,060,1841,449,614-1,545,416929,606-100,3231,825,237-1,582,5331,307,718
Cashflow From Financing100.0%--459,387---1,424,100----2,985,417----1,653,462----2,524,976----2,524,945
  Dividend Payments-100.0%-459,387--1,424,100---2,985,417---1,653,462---2,524,976---2,524,945

UG Income Statement

2023-12-31
Statements of Income - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net sales$ 10,885,154$ 12,698,503
Costs and expenses:  
Cost of sales5,479,5665,996,376
Operating expenses2,078,5642,174,127
Research and development463,992490,770
Total costs and expenses8,022,1228,661,273
Income from operations2,863,0324,037,230
Other (loss) income:  
Investment income306,651236,695
Net gain (loss) on marketable securities81,095(1,046,245)
Total other income (expense)387,746(809,550)
Income before provision for income taxes3,250,7783,227,680
Provision for income taxes669,408658,168
Net income$ 2,581,370$ 2,569,512
Earnings per common share (basic and diluted) (in dollars per share)$ 0.56$ 0.56
Weighted average shares (basic and diluted) (in shares)4,594,3194,594,319

UG Balance Sheet

2023-12-31
Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 8,243,122$ 830,452
Marketable securities851,3185,653,516
Accounts receivable, net of allowance for credit losses of $16,672 in 2023 and $20,063 in 20221,566,8391,427,576
Inventories, net1,223,5061,672,012
Prepaid expenses and other current assets191,708201,846
Prepaid income taxes176,220185,228
Total current assets12,252,7139,970,630
Deferred income taxes, net50,930110,544
Property, plant, and equipment:  
Land69,00069,000
Factory equipment and fixtures4,669,9364,585,055
Building and improvements2,976,5772,895,742
Total property, plant and equipment7,715,5137,549,797
Less accumulated depreciation7,096,3186,990,636
Total property, plant, and equipment, net619,195559,161
TOTAL ASSETS12,922,83810,640,335
Current liabilities:  
Accounts payable134,44930,415
Accrued expenses1,363,0441,322,056
Deferred revenue15,4980
Dividends payable21,26521,220
Total current liabilities1,534,2561,373,691
Commitments and Contingencies 
Stockholders’ equity:  
Common stock, $.10 par value; 10,000,000 shares authorized; 4,594,319 shares issued and outstanding at December 31, 2023 and 2022459,432459,432
Retained earnings10,929,1508,807,212
Total stockholders’ equity11,388,5829,266,644
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 12,922,838$ 10,640,335
UG
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.
 WEBSITEu-g.com
 INDUSTRYHousehold Products
 EMPLOYEES23

United-Guardian Inc Frequently Asked Questions


What is the ticker symbol for United-Guardian Inc? What does UG stand for in stocks?

UG is the stock ticker symbol of United-Guardian Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of United-Guardian Inc (UG)?

As of Wed Apr 24 2024, market cap of United-Guardian Inc is 38.09 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of UG stock?

You can check UG's fair value in chart for subscribers.

What is the fair value of UG stock?

You can check UG's fair value in chart for subscribers. The fair value of United-Guardian Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of United-Guardian Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for UG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is United-Guardian Inc a good stock to buy?

The fair value guage provides a quick view whether UG is over valued or under valued. Whether United-Guardian Inc is cheap or expensive depends on the assumptions which impact United-Guardian Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for UG.

What is United-Guardian Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, UG's PE ratio (Price to Earnings) is 14.75 and Price to Sales (PS) ratio is 3.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on United-Guardian Inc's stock?

In the past 10 years, United-Guardian Inc has provided -0.077 (multiply by 100 for percentage) rate of return.